TuHURA Biosciences, Inc.
HURA
$1.81
-$0.03-1.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.42% | -42.91% | -11.15% | -7.47% | -5.96% |
| Total Depreciation and Amortization | 58.96% | -4.96% | -19.89% | -39.52% | -18.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -74.37% | 58.94% |
| Total Other Non-Cash Items | 38.32% | -1.24% | 32.00% | 335.03% | -60.15% |
| Change in Net Operating Assets | -420.78% | 280.81% | -77.10% | 51.50% | 259.69% |
| Cash from Operations | -77.44% | -31.86% | -82.27% | 19.48% | 36.27% |
| Capital Expenditure | 100.00% | 86.89% | -99.53% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 86.39% | 81.51% | -15.45% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 86.40% | -39.77% | 84.14% | -14,125.75% |
| Total Debt Issued | -- | -- | -- | -100.00% | -32.93% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -31.38% | 1,691.17% | 3,553.62% | -99.80% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.00% | -- | -- | -- |
| Other Financing Activities | -5.01% | 68.44% | 61.57% | -229.46% | 31.62% |
| Cash from Financing | -39.40% | 1,687.44% | 84.42% | -122.39% | 21.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -353.62% | 135.62% | 7.23% | -195.25% | -7.20% |